Cyclerion Therapeutics Inc (CYCN)vsRevolution Medicines Inc (RVMD)
CYCN
Cyclerion Therapeutics Inc
$2.98
-2.61%
HEALTHCARE · Cap: $12.90M
RVMD
Revolution Medicines Inc
$155.69
+4.02%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Cyclerion Therapeutics Inc generates 169% more annual revenue ($1.99M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -264.7%. RVMD earns a higher WallStSmart Score of 24/100 (F).
CYCN
Avoid21
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+70.6%
Fair Value
$4.15
Current Price
$2.98
$1.17 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -77.7% — below average capital efficiency
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : CYCN
The strongest argument for CYCN centers on Price/Book.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : CYCN
The primary concerns for CYCN are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
CYCN profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
CYCN carries more volatility with a beta of 1.77 — expect wider price swings.
CYCN is growing revenue faster at -43.2% — sustainability is the question.
CYCN generates stronger free cash flow (-1M), providing more financial flexibility.
Bottom Line
RVMD scores higher overall (24/100 vs 21/100). CYCN offers better value entry with a 70.6% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cyclerion Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of drugs for serious diseases of the central nervous system (CNS). The company is headquartered in Cambridge, Massachusetts.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?